🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the safety and tolerability of the addition of immunos...
Status
Terminated
Location
NYU Cancer Institute
Start Date
2014-03
Trial ID
NCT02061449
Treatments Being Tested
Pilot Immunotherapy Study of Combination Prostate Specific Membrane Antigen...
Status
Completed
Location
H. Lee Moffitt Cancer Center & Research Institute
Start Date
2008-12-02
Trial ID
NCT00694551
Treatments Being Tested
The early clinical development paradigm for chemotherapeutic agents has sig...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2015-12-03
Trial ID
NCT02510950
Treatments Being Tested
The incidence of melanoma is increasing with an estimated incidence of 59,9...
Status
Completed
Location
New York University Langone Medical Center
Start Date
2010-09
Trial ID
NCT01079741
Treatments Being Tested
Gliomas are a heterogeneous group of tumors arising from glial cells in the...
Status
Recruiting
Location
Biogenea Pharmaceuticals Ltd
Start Date
2025-07-01
Trial ID
NCT07077616
The purpose of this study is to test the safety of a course of injections c...
Status
Terminated
Location
Icahn School of Medicine at Mount Sinai
Start Date
2013-11
Trial ID
NCT01984892
Treatments Being Tested
The purpose of this study is to determine whether the combination of a neoa...
Status
Not Yet Recruiting
Location
Johns Hopkins SKCCC
Start Date
2026-09
Trial ID
NCT07430202
Treatments Being Tested
The most important consideration in the design of this clinical trial is to...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-09-29
Trial ID
NCT02427581
Treatments Being Tested
This is a multi-center, randomized, double-blind clinical trial to assess t...
Status
Completed
Location
University of Maryland Greenebaum Cancer Center
Start Date
2017-03-30
Trial ID
NCT02873819
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of SL-701...
Status
Completed
Location
University of Alabama
Start Date
2014-05
Trial ID
NCT02078648